Abstract
Purpose
Homozygous mutations in the HAX1 gene cause an autosomal recessive form of severe congenital neutropenia (SCN). There are limited data on cases of gonadal insufficiency that involve the HAX1 gene mutation. We aimed to evaluate the pubertal development and gonadal functions of our patients with a p.Trp44X mutation in the HAX1 gene.
Method
Pubertal development, physical and laboratory findings of one male and seven female patients with HAX1 deficiency were evaluated.
Results
The age of the patients was between 13 and 25 years. All female patients were diagnosed with primary ovarian insufficiency (POI) based on amenorrhea and elevated gonadotropins. The ovary volumes in female patients were determined to be smaller than normal for their age through sonographic studies. Short stature associated with gonadal insufficiency was also observed in three patients.
Conclusion
The HAX1 gene is important for ovarian development, in which a p.Trp44X mutation may cause POI in female patients. It is crucial to follow up and evaluate the gonadal functions of female patients in such cases.
Similar content being viewed by others
References
Kostman R. Infantile genetic agranulocytosis. A new recessive lethal disease in man. Acta Paediatr Scand. 1956;45:1–78.
Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007;39:86–92.
Cox L, Liu JH. Primary ovarian insufficiency: an update. Int J Womens Health. 2014;6:235–43.
Nelson LM. Primary ovarian insufficiency. N Engl JMed. 2009;360:606–14.
Carlsson G, Kriström B, Nordenskjöld M, Henter JI, Fadeel B. Ovarian failure in HAX1-deficient patients: is there a gender-specific difference in pubertal development in severe congenital neutropenia or Kostmann disease? Acta Paediatr. 2013;102:78–82.
Gilsanz V, Ratib O. Hand bone age: a digital atlas of skeletal maturity. 2nd ed. New York: Springer; 2012.
Hanew K, Utsumi A. The role of endogenous GHRH in arginine-, insulin-, clonidine- and l-dopa-induced GH release in normal subjects. Eur J Endocrinol. 2002;146:197–202.
Hilczer M, Smyczynska J, Lewinski A. Limitations of clinical utility of growth hormone stimulating tests in diagnosing children with short stature. Endocr Regul. 2006;40:69–75.
Hauck F, Klein C. Pathogenic mechanisms and clinical implications of congenital neutropenia syndromes. Curr Opin Allergy Clin Immunol. 2013;13:596–606.
Smith BN, Ancliff PJ, Pizzey A, Khwaja A, Linch DC, Gale RE. Homozygous HAX1 mutations in severe congenital neutropenia patients with sporadic disease: a novel mutation in two unrelated British kindreds. Br J Haematol. 2009;144:762–70.
Ishikawa N, Okada S, Miki M, Shirao K, Kihara H, Tsumura M, et al. Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J Med Genet. 2008;45:802–7.
Germeshausen M, Grudzien M, Zeidler C, et al. Novel HAX1 mutations in patients with severe congenital neutropenia reveal isoform-dependent genotype-phenotype associations. Blood. 2008;111:4954–7.
Roques G, Munzer M, Barthez MA, et al. Neurological findings and genetic alterations in patients with Kostmann syndrome and HAX1 mutations. Pediatr Blood Cancer. 2014;61:1041–8.
Carlsson G, van’t Hooft I, Melin M, et al. Central nervous system involvement in severe congenital neutropenia: neurological and neuropsychological abnormalities associated with specific HAX1 mutations. J Intern Med. 2008;264:388–400.
Lees DM, Hart IR, Marshall JF. Existence of multiple isoforms of HS1-associated protein X-1 in murine and human tissues. J Mol Biol. 2008;379:645–55.
Kilpinen S, Autio R, Ojala K, et al. Systematic bioinformatic analysis of expression levels of 17,330 human genes across 9,783 samples from 175 types of healthy and pathological tissues. Genome Biol. 2008;9:R139.
Grzybowska EA, Sarnowska E, Konopiński R, Wilczyńska A, Sarnowski TJ, Siedlecki JA. Identification and expression analysis of alternative splice variants of the rat HAX-1 gene. Gene. 2006;371:84–92.
Langer JE, Oliver ER, Lev-Toaff AS, Coleman BG. Imaging of the female pelvis through the life cycle. Radiographics. 2012;32:1575–97.
Nelson LM, Anasti JN, Flack MR. Premature ovarian failure. In: Adashi EY, Rock JA, Rosenwaks Z, editors. Reproductive endocrinology, surgery, and technology. Philadelphia: Lippincott–Raven; 1996. p. 1393–410.
Committee opinion no. 605: primary ovarian insufficiency in adolescents and young women. Obstet Gynecol. 2014;124:193–7.
Rogol AD. Sex steroids, growth hormone, leptin and the pubertal growth spurt. Endocr Dev. 2010;17:77–85.
Kawai N, Kanzaki S, Watou ST, et al. Serum free insulin-like growth factor I (IGF-1), total IGF-1 and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency. J Clin Endocrinol Metab. 1999;84:82–9.
Yakar S, Rosen CJ, Beamer WG, et al. Circulating levels of IGF-1 directly regulate bone growth and density. J Clin Invest. 2002;110:771–81.
Kanbur-Oksüz N, Derman O, Kinik E. Correlation of sex steroids with IGF-1 and IGFBP-3 during different pubertal stages. Turk J Pediatr. 2004;46:315–21.
Cook JS, Hoffman RP, Stene MA, Hansen JR. Effects of maturational stage on insulin sensitivity during puberty. J Clin Endocrinol Metab. 1993;77:725–30.
Acknowledgments
This study was supported through “The Scientific and Technological Research Council of Turkey (TUBITAK)”. TUBITAK-Project No.: SBAG-HD-650 (110S513).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the ethical committee of the Uludag University Faculty of Medicine.
Conflict of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Cekic, S., Saglam, H., Gorukmez, O. et al. Delayed Puberty and Gonadal Failure in Patients with HAX1 Mutation. J Clin Immunol 37, 524–528 (2017). https://doi.org/10.1007/s10875-017-0412-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-017-0412-8